Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: A questionnaire

Open Rheumatology Journal

Volumn 2, Issue , 2008, Pages 58-63

  Rentero, Maria Luz ^a   Carbonell, Cristina ^b   Casillas, Marta ^a   Béjar, Milagros González ^c   Berenguer, Rafael ^d  

^a ELI LILLY AND COMPANY   (Spain)

^b ABS Universitat   (Spain)

^c CS Montesa   (Spain)

^d CS Algemesi   (Spain)

Author keywords

Osteoporosis; Postmenopausal women; Primary health care; Risk factors

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; INSULIN; LITHIUM; RALOXIFENE; TIBOLONE; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT LOSS; BONE METABOLISM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FRACTURE; HEALTH CARE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; KYPHOSIS; LIFESTYLE MODIFICATION; METABOLIC BONE DISEASE; OSTEOPOROSIS; PATIENT HEALTH QUESTIONNAIRE; PHYSICAL EXAMINATION; POSTMENOPAUSE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING; UROLITHIASIS;

EID: 85056074940     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312900802010058     Document Type: Article

References (35)

1. U.S. Department of Health and Human Services. Bone health and osteoporosis: A report of the Surgeon General. Rockville, MD, U.S. Department of Health and Human Services, Office of the Surgeon General; 2004.
2. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. (WHO Technical Report Series, No. 843). World Health Organization, Geneva, 1994.
3. Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12(1): 24-35.
4. Lippuner K, Golder M, Greiner R. Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 2005; 16 (Suppl 2): S8-S17.
5. Maravic M, Le Bihan C, Landais P, Fardellone P. Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int 2005; 16(12): 1475-80.
6. Prevention and Management of Osteoporosis: Report of a WHO Scientific Group (WHOTechnical Report Series, No. 921) World Health Organization; Geneva. 2003.
7. Díez Curiel M, García JJ, Carrasco JL, et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin 2001; 116: 86-8.
8. McGrother CW, Donaldson MM, Clayton D, Abrams KR, Clarke M. Evaluation of a hip fracture risk score for assessing elderly women. The melton osteporotic fracture (MOF) study. Osteo-poros Int 2002; 13 (1): 89-96.
9. Von Mühlen D, Visby Lunde A, Barrett-Connor E, Bettencourt R. Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in older Caucasian women. The Rancho Bernardo study. Osteoporos Int 1999; 10 (1): 79-84.
10. González-Macías J, Marín F, Vila J, et al. Prevalencia de factores de riesgo de osteoporosis y fracturas osteoporóticas en una serie de 5.195 mujeres mayores de 65 años. Med Clin 2004; 123(3): 85-9.
11. Weinstein L, Ullery B, Bourguignon C. A simple system to determine who needs osteoporosis screening. Obstet Gynecol 1999; 93(5 Part 1): 757-60.
12. Jönsson B. Targeting high-risk populations. Osteoporos Int 1998; 8 (Suppl 1): S13-S16.
13. EMEA. Notice to marketing authorization holders. Pharmacovigilance guidelines. Available from http://www.emea.europa.eu/pdfs/human/phvwp/161801en.pdf (Accessed date: 2008 Oct 17).
14. Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int 2001; 12(10): 811-22.
15. Kirk JK, Spangler JG, Celestino FS. Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older. Pharmacotherapy 2000; 20(4): 405-9.
16. Carter ND, Khan KM, McKay HA, et al. Community-based exercise program reduces risk factors for falls in 65-to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 2002; 167(9): 997-1004. Erratum in: CMAJ 2003; 168(2): 152.
17. van der Voort DJ, Geusens PP, Dinant GJ. Risk factors for osteoporosis related to their outcome: fractures. Osteoporos Int 2001; 12(8): 630-8.
18. van Geel AC, Geusens PP, Nagtzaam IF, et al. Timing and risk factors for clinical fractures among postmenopausal women: A 5year prospective study. BMC Med 2006; 4: 24.
19. Leslie WD, Metge C, Ward L. Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int 2003; 14(4): 334-8.
20. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
21. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12(7): 519-28.
22. Olmos JM, Martínez J, García J, Matorras P, Moreno JJ, González-Macías J. Incidencia de fractura de cadera en Cantabria. Med Clin 1992; 99: 729-31.
23. Cadarette SM, Jaglal SB, Murray TM, et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy Xray absorptiometry. JAMA 2001; 286(1): 57-63.
24. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 2001; 286 (22): 2815-22.
25. Miller PD, Siris ES, Barrett-Connor E, et al. Prediction of fracture risk in postmenopausal women with peripheral bone densitometry: Evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 2002; 17(12): 2222-30.
26. Dargent-Molina P, Poitiers F, Breart G, for the EPIDOS group. In Elderly Women Weight is the Best Predictor of a Very Low Bone Mineral Density: Evidence from the EPIDOS Study. Osteoporos Int 2000; 11(10): 881-8.
27. Grainge MJ, Coupland CAC, Cliffe SJ, Chilvers CED, Hosking DJ. Association between a family history of fractures and bone mineral density in early postmenopausal women. Bone 1999; 24(5): 507-12.
28. Ill PO, Alexandre C. Tobacco as risk factor of osteoporosis, myth or reality? Rev Rhum Ed Fr 1993; 60(4): 280-6.
29. Adami S, Giannini S, Giorgino R, et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study. Calcif Tissue Int 2004; 74(4): 317-2.
30. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density. The Women’s Health Initiative randomised trial. JAMA 2003; 290(13): 1729-38.
31. Ismail AA, O'Neill TW, Cockerill W, et al. Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int 2000; 11(3): 248-54.
32. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. The accuracy of self-reported fractures in older people. J Clin Epidemiol 2002; 55(5): 452-7.
33. Adami S, Giannini S, Giorgino R, et al. The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study. Osteoporos Int 2003; 14(3): 198-207.
34. Papaioannou A, Joseph L, Ioannidis G, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2005; 16(5): 568-78.
35. Ross PD. Risk factors for osteoporotic fracture. Endocrinol Metab Clin North Am 1998; 27(2): 289-301.